Vasiliki Xirou

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Myrto Moutafi, Charles T. Robbins, Vesal Yaghoobi et al. · Laboratory Investigation · 2022 · 140 citations

Medicine, Molecular Biology, Oncology +13

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis et al. · Cancer Research Communications · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +14

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Saba Shafi, Thazin Nwe Aung, Vasiliki Xirou et al. · Laboratory Investigation · 2022 · 17 citations · Full text

Medicine, Cancer Biology, Oncology +12

High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Myrto Moutafi, Katherine Bates, Thazin Nwe Aung et al. · Journal for ImmunoTherapy of Cancer · 2024 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17